TY - JOUR
T1 - CAPRIN1 haploinsufficiency causes a neurodevelopmental disorder with language impairment, ADHD and ASD
AU - Pavinato, Lisa
AU - Delle Vedove, Andrea
AU - Carli, Diana
AU - Ferrero, Marta
AU - Carestiato, Silvia
AU - Howe, Jennifer L.
AU - Agolini, Emanuele
AU - Coviello, Domenico A.
AU - Van De Laar, Ingrid
AU - Au, Ping Yee Billie
AU - Di Gregorio, Eleonora
AU - Fabbiani, Alessandra
AU - Croci, Susanna
AU - Mencarelli, Maria Antonietta
AU - Bruno, Lucia P.
AU - Renieri, Alessandra
AU - Veltra, Danai
AU - Sofocleous, Christalena
AU - Faivre, Laurence
AU - Mazel, Benoit
AU - Safraou, Hana
AU - DenommCrossed D sign©-Pichon, Anne Sophie
AU - Van Slegtenhorst, Marjon A.
AU - Giesbertz, Noor
AU - Van Jaarsveld, Richard H.
AU - Childers, Anna
AU - Rogers, R. Curtis
AU - Novelli, Antonio
AU - De Rubeis, Silvia
AU - Buxbaum, Joseph D.
AU - Scherer, Stephen W.
AU - Ferrero, Giovanni Battista
AU - Wirth, Brunhilde
AU - Brusco, Alfredo
N1 - Publisher Copyright:
© 2022 The Author(s). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved.
PY - 2023/2/1
Y1 - 2023/2/1
N2 - We describe an autosomal dominant disorder associated with loss-of-function variants in the Cell cycle associated protein 1 (CAPRIN1; MIM∗601178). CAPRIN1 encodes a ubiquitous protein that regulates the transport and translation of neuronal mRNAs critical for synaptic plasticity, as well as mRNAs encoding proteins important for cell proliferation and migration in multiple cell types. We identified 12 cases with loss-of-function CAPRIN1 variants, and a neurodevelopmental phenotype characterized by language impairment/speech delay (100%), intellectual disability (83%), attention deficit hyperactivity disorder (82%) and autism spectrum disorder (67%). Affected individuals also had respiratory problems (50%), limb/skeletal anomalies (50%), developmental delay (42%) feeding difficulties (33%), seizures (33%) and ophthalmologic problems (33%). In patient-derived lymphoblasts and fibroblasts, we showed a monoallelic expression of the wild-type allele, and a reduction of the transcript and protein compatible with a half dose. To further study pathogenic mechanisms, we generated sCAPRIN1+/- human induced pluripotent stem cells via CRISPR-Cas9 mutagenesis and differentiated them into neuronal progenitor cells and cortical neurons. CAPRIN1 loss caused reduced neuronal processes, overall disruption of the neuronal organization and an increased neuronal degeneration. We also observed an alteration of mRNA translation in CAPRIN1+/- neurons, compatible with its suggested function as translational inhibitor. CAPRIN1+/- neurons also showed an impaired calcium signalling and increased oxidative stress, two mechanisms that may directly affect neuronal networks development, maintenance and function. According to what was previously observed in the mouse model, measurements of activity in CAPRIN1+/- neurons via micro-electrode arrays indicated lower spike rates and bursts, with an overall reduced activity. In conclusion, we demonstrate that CAPRIN1 haploinsufficiency causes a novel autosomal dominant neurodevelopmental disorder and identify morphological and functional alterations associated with this disorder in human neuronal models.
AB - We describe an autosomal dominant disorder associated with loss-of-function variants in the Cell cycle associated protein 1 (CAPRIN1; MIM∗601178). CAPRIN1 encodes a ubiquitous protein that regulates the transport and translation of neuronal mRNAs critical for synaptic plasticity, as well as mRNAs encoding proteins important for cell proliferation and migration in multiple cell types. We identified 12 cases with loss-of-function CAPRIN1 variants, and a neurodevelopmental phenotype characterized by language impairment/speech delay (100%), intellectual disability (83%), attention deficit hyperactivity disorder (82%) and autism spectrum disorder (67%). Affected individuals also had respiratory problems (50%), limb/skeletal anomalies (50%), developmental delay (42%) feeding difficulties (33%), seizures (33%) and ophthalmologic problems (33%). In patient-derived lymphoblasts and fibroblasts, we showed a monoallelic expression of the wild-type allele, and a reduction of the transcript and protein compatible with a half dose. To further study pathogenic mechanisms, we generated sCAPRIN1+/- human induced pluripotent stem cells via CRISPR-Cas9 mutagenesis and differentiated them into neuronal progenitor cells and cortical neurons. CAPRIN1 loss caused reduced neuronal processes, overall disruption of the neuronal organization and an increased neuronal degeneration. We also observed an alteration of mRNA translation in CAPRIN1+/- neurons, compatible with its suggested function as translational inhibitor. CAPRIN1+/- neurons also showed an impaired calcium signalling and increased oxidative stress, two mechanisms that may directly affect neuronal networks development, maintenance and function. According to what was previously observed in the mouse model, measurements of activity in CAPRIN1+/- neurons via micro-electrode arrays indicated lower spike rates and bursts, with an overall reduced activity. In conclusion, we demonstrate that CAPRIN1 haploinsufficiency causes a novel autosomal dominant neurodevelopmental disorder and identify morphological and functional alterations associated with this disorder in human neuronal models.
KW - ADHD
KW - ASD
KW - CAPRIN1
KW - RNG105
KW - neurodevelopment
UR - http://www.scopus.com/inward/record.url?scp=85158143039&partnerID=8YFLogxK
U2 - 10.1093/brain/awac278
DO - 10.1093/brain/awac278
M3 - Article
C2 - 35979925
AN - SCOPUS:85158143039
SN - 0006-8950
VL - 146
SP - 534
EP - 548
JO - Brain
JF - Brain
IS - 2
ER -